Medtronic Plc shares are poised for a potential 4% swing when the medical device manufacturer reports its quarterly earnings on Sept. 1 before the market opens, according to options data compiled by Bloomberg.
The projected move aligns with the company’s recent earnings-announcement volatility, with implied moves over the past two years ranging from 3.0% to 4.1%. In five of the last eight earnings releases, Medtronic’s actual stock movement exceeded the options-implied estimate.
The most recent earnings report on June 3 saw the stock move just 0.5%, falling short of the 4.1% implied move at the time. By contrast, the February 2026 release triggered a 5.2% decline, surpassing the 3.6% implied move. The largest movement in the past eight quarters occurred in November 2025, when shares surged 8.8%—more than double the 3.6% implied move. The smallest deviation was in May 2025, with a 0.8% decline against a 3% implied move.
Medtronic, listed on the NYSE under the ticker MDT, is a medical device manufacturer. Options traders and investors will monitor the earnings release for updates on revenue, profit margins, and guidance amid ongoing market scrutiny of healthcare sector performance.
